No Data
No Data
Truist Financial Maintains Labcorp Holdings(LH.US) With Buy Rating, Maintains Target Price $285
Truist Financial Remains a Buy on Labcorp Holdings (LH)
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million
Labcorp: Acquired Assets Currently Generate $85M-$100M Annual Revenue >LH OPK
Labcorp Holdings To Buy Select Assets of OPKO's BioReference Health Unit >LH OPK
Express News | Labcorp: Purchase Price for Transaction Is up to $225 Mln